Medtronic EBITDA Margin 2010-2024 | MDT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of October 31, 2024 is .
| Medtronic EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-10-31 | $33.00B | $8.05B | 24.40% |
| 2024-07-31 | $32.58B | $7.79B | 23.92% |
| 2024-04-30 | $32.36B | $7.79B | 24.08% |
| 2024-01-31 | $32.32B | $8.33B | 25.78% |
| 2023-10-31 | $31.96B | $8.27B | 25.88% |
| 2023-07-31 | $31.56B | $8.33B | 26.40% |
| 2023-04-30 | $31.23B | $8.18B | 26.20% |
| 2023-01-31 | $30.77B | $8.30B | 26.96% |
| 2022-10-31 | $30.81B | $8.56B | 27.78% |
| 2022-07-31 | $31.07B | $8.72B | 28.07% |
| 2022-04-30 | $31.69B | $8.46B | 26.70% |
| 2022-01-31 | $31.79B | $8.39B | 26.39% |
| 2021-10-31 | $31.80B | $8.01B | 25.20% |
| 2021-07-31 | $31.60B | $7.37B | 23.34% |
| 2021-04-30 | $30.12B | $7.19B | 23.86% |
| 2021-01-31 | $27.93B | $5.89B | 21.08% |
| 2020-10-31 | $27.87B | $6.23B | 22.37% |
| 2020-07-31 | $27.93B | $6.65B | 23.83% |
| 2020-04-30 | $28.91B | $7.45B | 25.78% |
| 2020-01-31 | $31.06B | $9.08B | 29.23% |
| 2019-10-31 | $30.89B | $8.99B | 29.12% |
| 2019-07-31 | $30.67B | $9.17B | 29.89% |
| 2019-04-30 | $30.56B | $8.93B | 29.21% |
| 2019-01-31 | $30.56B | $8.91B | 29.15% |
| 2018-10-31 | $30.38B | $8.79B | 28.94% |
| 2018-07-31 | $29.95B | $9.17B | 30.61% |
| 2018-04-30 | $29.95B | $9.28B | 31.00% |
| 2018-01-31 | $29.73B | $9.07B | 30.52% |
| 2017-10-31 | $29.64B | $8.86B | 29.88% |
| 2017-07-31 | $29.93B | $8.41B | 28.09% |
| 2017-04-30 | $29.71B | $8.30B | 27.94% |
| 2017-01-31 | $29.36B | $8.21B | 27.96% |
| 2016-10-31 | $29.01B | $8.40B | 28.96% |
| 2016-07-31 | $28.73B | $8.28B | 28.83% |
| 2016-04-30 | $28.83B | $8.21B | 28.47% |
| 2016-01-31 | $28.57B | $6.76B | 23.67% |
| 2015-10-31 | $25.95B | $6.24B | 24.03% |
| 2015-07-31 | $23.26B | $5.63B | 24.22% |
| 2015-04-30 | $20.26B | $5.15B | 25.41% |
| 2015-01-31 | $17.52B | $4.83B | 27.55% |
| 2014-10-31 | $17.37B | $4.52B | 26.01% |
| 2014-07-31 | $17.20B | $4.54B | 26.39% |
| 2014-04-30 | $17.01B | $4.67B | 27.47% |
| 2014-01-31 | $16.90B | $5.58B | 33.04% |
| 2013-10-31 | $16.76B | $5.80B | 34.59% |
| 2013-07-31 | $16.67B | $5.79B | 34.71% |
| 2013-04-30 | $16.59B | $5.68B | 34.23% |
| 2013-01-31 | $16.43B | $5.68B | 34.58% |
| 2012-10-31 | $16.32B | $5.61B | 34.37% |
| 2012-07-31 | $16.25B | $5.66B | 34.81% |
| 2012-04-30 | $16.18B | $5.67B | 35.01% |
| 2012-01-31 | $15.86B | $5.47B | 34.45% |
| 2011-10-31 | $15.80B | $5.46B | 34.57% |
| 2011-07-31 | $15.68B | $5.35B | 34.14% |
| 2011-04-30 | $15.51B | $5.27B | 34.00% |
| 2011-01-31 | $15.30B | $5.34B | 34.90% |
| 2010-10-31 | $15.30B | $5.46B | 35.71% |
| 2010-07-31 | $15.23B | $5.56B | 36.53% |
| 2010-04-30 | $15.39B | $5.65B | 36.73% |
| 2010-01-31 | $15.45B | $5.23B | 33.82% |
| 2009-10-31 | $15.09B | $4.91B | 32.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $117.214B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
| Boston Scientific (BSX) | United States | $151.377B | 43.52 |
| Stryker (SYK) | United States | $149.082B | 32.08 |
| EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
| GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
| ResMed (RMD) | United States | $37.119B | 30.50 |
| Terumo (TRUMY) | Japan | $28.886B | 41.07 |
| Koninklijke Philips (PHG) | Netherlands | $25.642B | 19.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
| Insulet (PODD) | United States | $19.438B | 77.40 |
| Baxter (BAX) | United States | $16.737B | 10.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
| ICU Medical (ICUI) | United States | $4.121B | 39.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.893B | 19.36 |
| Envista Holdings (NVST) | United States | $3.678B | 27.40 |
| Haemonetics (HAE) | United States | $3.430B | 16.74 |
| Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
| GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
| Neogen (NEOG) | United States | $2.495B | 28.75 |
| LeMaitre Vascular (LMAT) | United States | $2.247B | 54.60 |
| AtriCure (ATRC) | United States | $2.067B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
| InMode (INMD) | Israel | $1.462B | 8.79 |
| AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
| BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
| Owens & Minor (OMI) | United States | $1.150B | 8.99 |
| Evolus (EOLS) | United States | $0.922B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
| Surmodics (SRDX) | United States | $0.511B | 0.00 |
| Omeros (OMER) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
| Valneva SE (VALN) | France | $0.412B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Quanterix (QTRX) | United States | $0.370B | 0.00 |
| Cerus (CERS) | United States | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
| Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
| Biote (BTMD) | United States | $0.309B | 6.76 |
| OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
| Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
| Zynex (ZYXI) | United States | $0.263B | 55.13 |
| High Tide (HITI) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 104.70 |
| MacroGenics (MGNX) | United States | $0.190B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| INLIF (INLF) | $0.071B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.35 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |